Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-term Assessment of Safety and Efficacy of AMG 827 Treatment in Subjects With Crohn's Disease

NCT01199302 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT01199302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01199302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-term Assessment of Safety and Efficacy of AMG 827 Treatment in Subjects With Crohn's Disease
Lead sponsor
Amgen
Phase
Phase 2
Overall status
Terminated
Start date
February 2, 2011
Completion date
October 18, 2011
Enrollment
67 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease